As of 2026-10-06, the Fair Value of Emergent BioSolutions Inc (EBS) is -0.83 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.24 USD, the upside of Emergent BioSolutions Inc is -111.51%.
With the market price of 7.24 USD and our fair value calculation, Emergent BioSolutions Inc (EBS) is not a good investment. Investing in EBS stocks now will result in a potential loss of 111.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 219.50 | -211.60 | -760.50 | -190.60 | 52.60 | -178.12 |
| YoY growth | -28.06% | -196.40% | -259.40% | 74.94% | 127.60% | -56.27% |
| Market Cap (mil) | 373.58 |
| P/E | |
| Forward P/E | 8.87x |
| EPS | -0.17 |
| Avg earnings growth rate | -56.27% |
| TTM earnings | -8.60 |